Companhia Celg de Participacoes Celgpar News - GPAR3F

Cochlear Limited (CHEOF) Receives a Buy from Jarden

Jarden analyst Steven Wheen maintained a Buy rating on Cochlear Limited (CHEOF - Research Report) on August 22 and set a price target of A$232.01...

Cochlear Limited (CHEOF) Receives a Buy from Goldman Sachs

Goldman Sachs analyst Chris Cooper maintained a Buy rating on Cochlear Limited (CHEOF - Research Report) on August 19 and set a price target of...

Wilsons Remains a Buy on Cochlear Limited (CHEOF)

Wilsons analyst Shane Storey maintained a Buy rating on Cochlear Limited (CHEOF - Research Report) on August 22 and set a price target of...

Analysts Offer Insights on Healthcare Companies: Cochlear Limited (OtherCHEOF), Springworks Therapeutics (SWTX) and Galapagos (GLPG)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cochlear Limited (OtherCHEOF), Verve Therapeutics (VERV) and Allogene Therapeutics (ALLO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cochlear Limited (CHEOF – Research Report), Verve...

Jarden Thinks Cochlear Limited’s Stock is Going to Recover

E ratio of 50.27. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their...

Cochlear Limited (CHEOF) Gets a Hold Rating from Morgan Stanley

E ratio of 46.60. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their...

Cochlear Limited (CHEOF) Receives a Hold from Wilsons

According to TipRanks.com, Storey is a 1-star analyst with an average return of -12.0% and a 18.2% success rate. Storey covers the Healthcare...

Cochlear Limited (CHEOF) Gets a Buy Rating from Goldman Sachs

According to TipRanks.com, Cooper is a 3-star analyst with an average return of 6.0% and a 68.8% success rate. Cooper covers the Healthcare...

Jarden Remains a Buy on Cochlear Limited (CHEOF)

According to TipRanks.com, Wheen is ranked #4923 out of 7897 analysts. Cochlear Limited has an analyst consensus of Moderate Buy, with a price...

Macquarie Maintains a Hold Rating on Cochlear Limited (CHEOF)

E ratio of 53.95. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their...

Ord Minnett Reaffirms Their Hold Rating on Cochlear Limited (CHEOF)

E ratio of 53.95. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their...

Cochlear Limited (CHEOF) Gets a Buy Rating from Citigroup

E ratio of 54.62.https://www.tipranks.com/news/blurbs/cochlear-limited-cheof-gets-a-buy-rating-from-citigroup?utm_source=advfn.com&utm_medium=refer...

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Exact Sciences (EXAS) and Cochlear Limited (OtherCHEOF)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edwards Lifesciences (EW – Research Report), Exact Sciences...

Analysts Offer Insights on Healthcare Companies: Matinas BioPharma (MTNB) and Cochlear Limited (OtherCHEOF)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Matinas BioPharma (MTNB – Research Report) and...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Companhia Celg de Participacoes Celgpar (GPAR3F)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

GPAR3F News

Cochlear Limited (CHEOF) Receives a Buy from Jarden

Cochlear Limited (CHEOF) Receives a Buy from Goldman Sachs

Wilsons Remains a Buy on Cochlear Limited (CHEOF)

Analysts Offer Insights on Healthcare Companies: Cochlear Limited (OtherCHEOF), Springworks Therapeutics (SWTX) and Galapagos (GLPG)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cochlear Limited (OtherCHEOF), Verve Therapeutics (VERV) and Allogene Therapeutics (ALLO)

Jarden Thinks Cochlear Limited’s Stock is Going to Recover

Cochlear Limited (CHEOF) Gets a Hold Rating from Morgan Stanley

Cochlear Limited (CHEOF) Receives a Hold from Wilsons

Cochlear Limited (CHEOF) Gets a Buy Rating from Goldman Sachs

Jarden Remains a Buy on Cochlear Limited (CHEOF)

Macquarie Maintains a Hold Rating on Cochlear Limited (CHEOF)

Ord Minnett Reaffirms Their Hold Rating on Cochlear Limited (CHEOF)

Cochlear Limited (CHEOF) Gets a Buy Rating from Citigroup

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Exact Sciences (EXAS) and Cochlear Limited (OtherCHEOF)

Analysts Offer Insights on Healthcare Companies: Matinas BioPharma (MTNB) and Cochlear Limited (OtherCHEOF)

GPAR3F Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Companhia Celg de Participacoes Celgpar (GPAR3F) News

Companhia Celg de Participacoes Celgpar (GPAR3F)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

GPAR3F News

Cochlear Limited (CHEOF) Receives a Buy from Jarden

Cochlear Limited (CHEOF) Receives a Buy from Goldman Sachs

Wilsons Remains a Buy on Cochlear Limited (CHEOF)

Analysts Offer Insights on Healthcare Companies: Cochlear Limited (OtherCHEOF), Springworks Therapeutics (SWTX) and Galapagos (GLPG)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cochlear Limited (OtherCHEOF), Verve Therapeutics (VERV) and Allogene Therapeutics (ALLO)

Jarden Thinks Cochlear Limited’s Stock is Going to Recover

Cochlear Limited (CHEOF) Gets a Hold Rating from Morgan Stanley

Cochlear Limited (CHEOF) Receives a Hold from Wilsons

Cochlear Limited (CHEOF) Gets a Buy Rating from Goldman Sachs

Jarden Remains a Buy on Cochlear Limited (CHEOF)

Macquarie Maintains a Hold Rating on Cochlear Limited (CHEOF)

Ord Minnett Reaffirms Their Hold Rating on Cochlear Limited (CHEOF)

Cochlear Limited (CHEOF) Gets a Buy Rating from Citigroup

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Exact Sciences (EXAS) and Cochlear Limited (OtherCHEOF)

Analysts Offer Insights on Healthcare Companies: Matinas BioPharma (MTNB) and Cochlear Limited (OtherCHEOF)

GPAR3F Discussion

Your Recent History